B2M and breast cancer: Because the upregulation of B2M in the ICEC regions in ER+ breast cancers was among the most significant changes after ET, we sought to investigate the cancer cell–intrinsic effects of ER perturbation on MHC-I expression in ER+ breast cancer cell lines (MCF7, T47D, CAMA1, and ZR75.1).